Monocyte responsiveness towards different arteriogenic stimuli: A functional comparison of various chemoattractants and their combinations

• References

• 1 Caplice NM, Gersh BJ, Alegria JR. Cell therapy for cardiovascular disease: what cells, what diseases and for whom?. Nat Clin Pract Cardiovasc Med 2005; 02: 37-43.
• 2 Cao R, Brakenhielm E, Pawliuk R. et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 2003; 09: 604-13.
• 3 Ito WD, Arras M, Winkler B. et al. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 1997; 80: 829-37.
• 4 Herold J, Tillmanns H, Xing Z. et al. Isolation and transduction of monocytes: promising vehicles for therapeutic arteriogenesis. Langenbecks Arch Surg 2006; 391: 72-82.
• 5 Arras M, Ito WD, Scholz D. et al. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 1998; 101: 40-50.
• 6 Waltenberger J, Lange J, Kranz A. Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus. A potential predictor for the individual capacity to develop collaterals. Circulation 2000; 102: 185-90.
• 7 Barleon B, Sozzani S, Zhou D. et al. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996; 87: 3336-43.
• 8 Falk W, Leonard EJ. Human monocyte chemotaxis: migrating cells are a subpopulation with multiple chemotaxin specificities on each cell. Infect Immun 1980; 29: 953-9.
• 9 Jones GE, Prigmore E, Calvez R. et al. Requirement for PI 3-kinase gamma in macrophage migration to MCP-1 and CSF-1. Exp Cell Res 2003; 290: 120-31.
• 10 Gouwy M, Struyf S, Proost P. et al. Synergy in cytokine and chemokine networks amplifies the inflammatory response. Cytokine Growth Factor Rev 2005; 16: 561-80.
• 11 Van Belle E, Witzenbichler B, Chen D. et al. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation 1998; 97: 381-90.
• 12 Castellon R, Hamdi HK, Sacerio I. et al. Effects of angiogenic growth factor combinations on retinal endothelial cells. Exp Eye Res 2002; 74: 523-35.